SPRO
Spero Therapeutics, Inc.
+0.01 (+0.90%)1.12USD79.0K成交股數65.2M市值8.0本益比(近四季)5.2股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0 | 0-100% | 12.6M+19245% | 0-100% | 0-100% | 12K-95% | 65K-70% | 114K-58% | 140K | 223K | 218K | 269K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 3.4M | 2.9M | 5.6M | 8.6M | 10.7M | 13.6M | 26.9M | 23.7M | 17.3M | 16.6M | 16.4M | 9.5M |
| 銷售管理費用 | 6.5M | 4.9M | 4.3M | 4.2M | 5.9M | 6.8M | 5.2M | 5.5M | 5.9M | 6.4M | 5.7M | 6.1M |
| 營業利益 | −9.9M+306% | −7.5M-49% | 31.4M-269% | −7.9M-58% | −2.4M-83% | −14.7M-129% | −18.6M+861% | −19.1M+48% | −14.0M | 50.5M | −1.9M | −12.9M |
| 營業利益率 | – | – | 249.8% | – | – | -122,758.3% | -28,604.6% | -16,720.2% | -9,987.1% | 22,660.1% | -887.2% | -4,791.8% |
| 稅後淨利 | −9.6M+462% | −7.2M-48% | 31.5M-284% | −7.4M-59% | −1.7M-87% | −13.9M-127% | −17.1M+436% | −17.9M+50% | −12.7M | 51.2M | −3.2M | −11.9M |
| 淨利率 | – | – | 250.7% | – | – | -115,550.0% | -26,380.0% | -15,668.4% | -9,049.3% | 22,962.3% | -1,467.9% | -4,423.8% |
| 稀釋 EPS | -0.16+433% | -0.13-48% | 0.56-275% | -0.13-61% | -0.03-88% | -0.25-126% | -0.32+433% | -0.33+43% | -0.24 | 0.97 | -0.06 | -0.23 |
| 稀釋股數 | 58.0M | 57.3M | 59.0M | 56.3M | 56.0M | 55.4M | 54.1M | 54.0M | 53.5M | 53.0M | 52.7M | 52.6M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 50.8M | 56.1M | 40.3M | 48.6M | 31.2M | 48.9M | 76.3M | 63.5M | 82.3M | 76.3M | 93.8M | 77.7M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 52.8M | 59.0M | 68.9M | 54.2M | 62.1M | 77.7M | 135M | 150M | 168M | 182M | 107M | 98.9M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 8.6M | 6.1M | 9.9M | 27.7M | 29.3M | 43.9M | 69.7M | 69.4M | 71.5M | 75.5M | 53.4M | 44.1M |
| 股東權益 | 44.2M | 52.9M | 59.0M | 26.5M | 32.8M | 33.8M | 65.5M | 80.5M | 96.2M | 107M | 53.7M | 54.8M |
| 負債比 | 16.2% | 10.3% | 14.4% | 51.1% | 47.2% | 56.5% | 51.5% | 46.3% | 42.6% | 41.4% | 49.9% | 44.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 15.9M-496% | – | – | – | −4.0M | – | – | 5.9M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | 0 | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 66.8M
| Collaboration Revenue Related Party | 47.0M | 70.4% | +74.0% |
|---|---|---|---|
| Collaboration Revenue | 12.6M | 18.8% | +3292.5% |
| Grant Revenue | 7.2M | 10.8% | -65.1% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 12.6M | +3292.5% | 8.6M | 68.1% | 0.15 | – |
| FY2024 | 371K | -60.2% | −68.6M | -18,481.4% | -1.27 | – |
| FY2023 | 933K | -62.7% | 22.8M | 2,444.4% | 0.43 | – |
| FY2022 | 2.5M | -18.5% | −46.4M | -1,854.4% | -1.23 | – |
| FY2021 | 3.1M | +1089.9% | −89.8M | -2,925.1% | -2.91 | – |
| FY2020 | 258K | -94.6% | −78.3M | -30,348.8% | -3.52 | −86.0M |
| FY2019 | 4.7M | +19.6% | −60.9M | -1,284.3% | -3.35 | −50.3M |
| FY2018 | 4.0M | – | −41.7M | -1,051.4% | -2.60 | −42.1M |